Know more before you book.

The only FDA-approved sermorelin was discontinued, and no current label exists. What the trials recorded, and what the 2026 reviews warn about.

Mounjaro dosage charts skip the four-week floor and the 15 mg ceiling. The label does not, and two 2026 case reports show what the rush costs.

One registered trial gives MOTS-c to people. Its own record will not print the milligrams, and the charts selling you a schedule cannot either.

You found ‘research use only’ and treated it as permission. Four FDA letters dated 24 August 2026 say the label does not cover a vial made for a body.

The 44% nausea figure is a Wegovy number, not a semaglutide one. In the labels’ dose tables, the climb makes people sick and the top rung rarely does.

Ozempic side effect pages stop at nausea. The label’s newest warning covers severe GI reactions, and the first esophageal rupture came after a restart.

Five approved peptide drugs, four different injection maps. The labels name the zones, the rotation rule carries the weight of 51 studies, and the unapproved vials carry none of it.

You searched how to reconstitute peptides and found a video, not a label. FDA’s files list 17 substances whose safety record the agency could not close.

Semaglutide for weight loss averages 14.9% in the FDA label. The same table runs from 9.6% to 16%, and the label now allows a 7.2 mg dose. What the numbers…

Ozempic starts at 0.25 mg for four weeks and that month is a tolerance step. The label’s working doses, its 2 mg ceiling and its five-day missed-dose rule.